Skip to main navigation Skip to search Skip to main content

The Balance Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

Project: Research

Project Details

StatusFinished
Effective start/end date04/23/08 → 12/2/11

Funding

  • Cardiokine Biopharma, LLC: $13,530.00